Sarepta Therapeutics to Present Company Overview at the Credit Suisse 25th Annual Healthcare Conference

Webcast Accessible via Sarepta Therapeutics Website

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sarepta Therapeutics (NASDAQ: SRPT), a commercial-stage developer of innovative RNA-targeted therapeutics, announced today that it is scheduled to present at the Credit Suisse 25th Annual Healthcare Conference in Phoenix, Arizona on Monday, November 7, 2016 at 5:30 PM, Eastern Time. Edward Kaye, Sarepta's chief executive officer, will be the presenter at the fireside chat.

The presentation will be webcast live on the investor relations section of the Sarepta Therapeutics website at www.sarepta.com and will be archived under the events and presentations section following the presentation for 90 days. Please connect to Sarepta’s website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Sarepta Therapeutics

Sarepta Therapeutics is a commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare neuromuscular diseases. The Company is primarily focused on rapidly advancing the development of its potentially disease-modifying DMD drug candidates. For more information, please visit us at www.sarepta.com.

Internet Posting of Information

We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161104005220/en/

Media and Investors:
Sarepta Therapeutics, Inc.
Ian Estepan, 617-274-4052
[email protected]
or
W2O Group
Brian Reid, 212-257-6725
[email protected]

Source: Sarepta Therapeutics, Inc.

You May Also Be Interested In

• Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
• Aspen Aerogels to Participate in May Investor Conferences
• Month-End Portfolio Data Now Available for Ares Dynamic Credit Allocation Fund, Inc.